Navigation Links
Johns Hopkins University Researchers to Clinically Assess Rosetta Genomics' miRview(TM) Squamous Assay
Date:10/2/2008

tatements for the purposes of the safe harbor provisions under The Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those indicated by these forward-looking statements as a result of various important factors, including risks related to: Rosetta's approach to discover and develop novel diagnostics and therapeutic tools, which is unproven and may never lead to marketable products or services; Rosetta's ability to fund and the results of further pre-clinical and clinical trials; Rosetta's ability to obtain, maintain and protect the intellectual property utilized by Rosetta's products; Rosetta's ability to enforce its patents against infringers and to defend its patent portfolio against challenges from third parties; Rosetta's ability to obtain additional funding to support its business activities; Rosetta's dependence on third parties for development, manufacture, marketing, sales, and distribution of products; Rosetta's ability to successfully develop its candidate tools, products and services, all of which are in early stages of development; Rosetta's ability to obtain regulatory clearances or approvals that may be required for its products and services; the ability to obtain coverage and adequate payment from health insurers for the products and services comprising Rosetta's technology; competition from others using technology similar to Rosetta's and others developing products for similar uses; Rosetta's dependence on collaborators; and Rosetta's short operating history; as well as those risks more fully discussed in the "Risk Factors" section of Rosetta's Annual Report on Form 20-F for the year ended December 31, 2007 as filed with the Securities and Exchange Commission. In addition, any forward-looking statements represent Rosetta's views only as of the date of this release and should not be relied upon as representing its views as of any subsequent date. Rosetta does not assume any obligation to update any forward-look
'/>"/>
SOURCE Rosetta Genomics Ltd
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Duska Therapeutics Licenses Portfolio of Heart Failure Drugs From Duke and Johns Hopkins
2. Orion Genomics Gains Exclusive Worldwide Rights to the IGF2 Gene for Colorectal Cancer Risk Testing Through Licensing Agreement With Johns Hopkins University
3. Johnson & Johnson to Provide Webcast Presentation of Tapentadol Phase 3 Clinical Data Presented at American Pain Societys Annual Meeting
4. Peregrine Announces Addition of The Johns Hopkins Hospital as Study Site for Bavituximab Trial in HCV Patients Co-Infected With HIV
5. Hopkins Report: Focusing on Family Planning Lessens HIV Impact
6. Queens University Chooses Xceeds Ziplex(R) System for Translational Research
7. deCODE and Radboud University Discover Common Variants in the Human Genome Conferring Risk of Bladder Cancer
8. The University of Nottingham in the British Midlands Announces Breakthrough in Parkinsons Disease Research
9. Boston University and The Center for Human Genetics, Inc. Announce Change in Testing Services
10. First U.S. Patient to Receive New Heart-Assist Device Doing Well After Surgery at University of Michigan
11. University of Rochester Researcher Named Millennium Pharmaceuticals Career Development Scholar of The Leukemia & Lymphoma Society
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2014)... /PRNewswire-iReach/ -- Full Service CRO WCCT Global ... President of Business Development. Peter has been in the ... of different business development positions with some of the ... related to business development/sales management and marketing.  The experience ... him a key and strategic asset to WCCT Global ...
(Date:7/25/2014)... , July 25, 2014  The Chemistry, ... Tobago Ministry of Health approved the introduction of ... increases the cure rate from Hepatitis C, and ... genotype 1 virus. Telaprevir is available in ... INCIVO®. Photo - http://www2.prnewswire.com.br/imgs/pub/2014-07-25/original/2026.jpg   ...
(Date:7/25/2014)... , July 25, 2014  Solanbridge Group Inc ... acquired the majority interest in Buzznbrewz.com and the Letter ... replaced with a fully executed Purchase Agreement. ... stated "We are proud to have Mr. David ... decades of experience in the private sector and developed ...
Breaking Medicine Technology:Contract Research Organization WCCT Global Welcomes Peter Nieto as Vice President of Business Development 2The Hepatitis C virus is the main cause of liver transplant in the world 2The Hepatitis C virus is the main cause of liver transplant in the world 3Solanbridge Group Inc Announces Acquisition of Buzznbrewz.com 2
... , , CHARLOTTESVILLE, Virginia, December ... the 2009 Top Innovator Presentation Award,in Healthcare, at the ... Dedham, MA. The award, which recognizes cutting edge private ... who competed with,over 50 other privately held companies that ...
... , ... CVS/pharmacy and MinuteClinic health care centers located in select ... and Washington, D.C. While in some locations priority restrictions ... allowing all patients to be eligible to receive the shot ...
Cached Medicine Technology:Biovista Inc. Named Top Innovator in Life Sciences 2CVS/pharmacy and MinuteClinic Providing H1N1 Vaccines in 20 States and Washington, D.C. 2CVS/pharmacy and MinuteClinic Providing H1N1 Vaccines in 20 States and Washington, D.C. 3CVS/pharmacy and MinuteClinic Providing H1N1 Vaccines in 20 States and Washington, D.C. 4
(Date:7/28/2014)... new study of the European project SOPHIE has ... policies and gender inequalities in health in Europe. ... policies (central and southern Europe) and countries with ... self-perceived health, i.e. women reported poorer health than ... Europe countries, where women present a 27% higher ...
(Date:7/28/2014)... Termed by the Michigan Osteopathic Association ... fatal overdoses than heroin and cocaine combined, and takes ... are particularly vulnerable to succumbing to prescription overdose are ... in this age group taking at least seven different ... reawakened in the White House in the midst of ...
(Date:7/28/2014)... Karen Pallarito HealthDay ... U.S. taxpayers who go without health insurance this year will ... for a family of five, the Internal Revenue Service says. ... on the federal tax penalties that some Americans will owe ... cap is based on the monthly national average premium for ...
(Date:7/28/2014)... PA (PRWEB) July 28, 2014 "We ... kept shutting," said one of two inventors from Jamestown, ... the lids open so that we could pour medications ... the CONKLIN'S STAY OPEN to keep the lids open ... lids from closing until all compartments have been filled. ...
(Date:7/28/2014)... Community Health Center of Snohomish County (CHC), ... services, has released an article designed to educate patients ... Founded in 1983, the health center has a strong ... that face barriers to obtaining high quality yet affordable ... the CHC, click here: http://www.chcsno.org/locations.ashx?p=1099 , The ...
Breaking Medicine News(10 mins):Health News:Gender inequalities in health: A matter of policies 2Health News:Rx Drug Abuse Labeled Silent Killer: Claims Nearly 17,000 American Lives a Year; Novus Medical Detox Solution Involves Education and Governmental Support 2Health News:Rx Drug Abuse Labeled Silent Killer: Claims Nearly 17,000 American Lives a Year; Novus Medical Detox Solution Involves Education and Governmental Support 3Health News:Rx Drug Abuse Labeled Silent Killer: Claims Nearly 17,000 American Lives a Year; Novus Medical Detox Solution Involves Education and Governmental Support 4Health News:IRS Caps Fines on Uninsured Americans at $12K for Family of 5 2Health News:Community Health Center of Snohomish Releases Article Focusing on Educating the Chronically Ill About Chronic Disease Management 2Health News:Community Health Center of Snohomish Releases Article Focusing on Educating the Chronically Ill About Chronic Disease Management 3
... DURHAM, N.C. By targeting and disabling a protein ... to make the cancer more vulnerable to chemotherapy, according ... researchers in the Duke Comprehensive Cancer Center. , "In ... melanoma a compound that had been shown in pre-clinical ...
... BURLINGTON, Mass., March 6 Palomar Medical Technologies, Inc. ... developer of light-based systems for cosmetic treatments, announced today ... XD Optic(TM), the GROOVE Optic(TM), LuxPowR(TM) pulsed-light handpiece and ... the 67th Annual Meeting of the American Academy of ...
... March 6 ALOKA Co., Ltd. will be unveiling ... of Radiology - ECR2009 - to be held from ... generate demand for ultrasound systems with higher cost-effectiveness, flexibility, ... is a stand-alone, black-and-white system with the latest digital ...
... in German . , The combination ... of certain brain tumours. This has been demonstrated by researchers ... colleagues in a current study. They treated 39 patients who ... on average 23 months; with the standard therapy the mean ...
... cardiovascular nurse and allied professional are already at the ... disease, and Professor Christi Deaton, Chairperson of the ESC ... an even greater role given the complex needs of ... to prevent cardiovascular disease," says Professor Deaton, "and we ...
... colorectal cancer and removal of precancerous polyps among key ... Brook, Ill., March 6 /PRNewswire-USNewswire/ -- Colorectal ... of the most preventable cancers. Recent statistics show that ... diagnosed) and death rates from colorectal cancer are declining, ...
Cached Medicine News:Health News:Drug combination may be effective against deadly melanoma, pilot study shows 2Health News:Palomar Medical to Debut New Devices and a More Powerful Platform at the American Academy of Dermatology Annual Meeting 2Health News:Palomar Medical to Debut New Devices and a More Powerful Platform at the American Academy of Dermatology Annual Meeting 3Health News:Palomar Medical to Debut New Devices and a More Powerful Platform at the American Academy of Dermatology Annual Meeting 4Health News:Palomar Medical to Debut New Devices and a More Powerful Platform at the American Academy of Dermatology Annual Meeting 5Health News:Palomar Medical to Debut New Devices and a More Powerful Platform at the American Academy of Dermatology Annual Meeting 6Health News:ALOKA Showcases a New Diagnostic Ultrasound System ProSound 4 at ECR 2009 in Vienna, Austria 2Health News:Brain tumors: New therapy surprisingly successful 2Health News:Nurses and allied professionals at heart of cardiovascular prevention and management programs 2Health News:Nurses and allied professionals at heart of cardiovascular prevention and management programs 3Health News:March is National Colorectal Cancer Awareness Month: Do You Know What Your Screening Options Are? 2Health News:March is National Colorectal Cancer Awareness Month: Do You Know What Your Screening Options Are? 3Health News:March is National Colorectal Cancer Awareness Month: Do You Know What Your Screening Options Are? 4Health News:March is National Colorectal Cancer Awareness Month: Do You Know What Your Screening Options Are? 5Health News:March is National Colorectal Cancer Awareness Month: Do You Know What Your Screening Options Are? 6Health News:March is National Colorectal Cancer Awareness Month: Do You Know What Your Screening Options Are? 7
For the qualitative detection of single and multiple drugs and drug metabolites in human urine...
For the qualitative detection of single and multiple drugs and drug metabolites in human urine...
For the qualitative detection of single and multiple drugs and drug metabolites in human urine...
For the qualitative detection of cardiac troponin I (cTnl) in human whole blood and serum specimens...
Medicine Products: